ECSP10010425A - Pirrolopirimidincarboxamidas - Google Patents

Pirrolopirimidincarboxamidas

Info

Publication number
ECSP10010425A
ECSP10010425A EC2010010425A ECSP10010425A ECSP10010425A EC SP10010425 A ECSP10010425 A EC SP10010425A EC 2010010425 A EC2010010425 A EC 2010010425A EC SP10010425 A ECSP10010425 A EC SP10010425A EC SP10010425 A ECSP10010425 A EC SP10010425A
Authority
EC
Ecuador
Prior art keywords
salts
compounds
oxides
pirrolopirimidincarboxamidas
stereoisomers
Prior art date
Application number
EC2010010425A
Other languages
English (en)
Inventor
Torsten Dunkern
Josef Stadlwieser
Beate Schmidt
Heiko Bernsmann
Alexander Sudau
Degenhard Mark
Joerg Diefenbach
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of ECSP10010425A publication Critical patent/ECSP10010425A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los compuestos de la fórmula (I) en donde R1, R21, R22, R23, R24, Y y R3 tienen los significados dados en la descripción, las sales de los mismos, los N-óxidos de los compuestos, y las sales de los mismos y los estereoisómeros de los compuestos, las sales, los N-óxidos de los compuestos y los N-óxidos de las sales de los mismos, son efectivos inhibidores de la fosfodiesterasa tipo 5.
EC2010010425A 2008-02-27 2010-08-25 Pirrolopirimidincarboxamidas ECSP10010425A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08102052 2008-02-27

Publications (1)

Publication Number Publication Date
ECSP10010425A true ECSP10010425A (es) 2010-09-30

Family

ID=39855184

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010425A ECSP10010425A (es) 2008-02-27 2010-08-25 Pirrolopirimidincarboxamidas

Country Status (20)

Country Link
US (1) US8445501B2 (es)
EP (1) EP2247594A1 (es)
JP (1) JP5615187B2 (es)
KR (1) KR20100136469A (es)
CN (1) CN101959890B (es)
AR (1) AR070454A1 (es)
AU (1) AU2009218507B2 (es)
BR (1) BRPI0907863A2 (es)
CA (1) CA2711733A1 (es)
CO (1) CO6341477A2 (es)
EA (1) EA018331B1 (es)
EC (1) ECSP10010425A (es)
IL (1) IL207639A (es)
MX (1) MX2010009276A (es)
MY (1) MY152061A (es)
NZ (1) NZ586486A (es)
SG (1) SG188823A1 (es)
TW (1) TW200944527A (es)
UA (1) UA101018C2 (es)
WO (1) WO2009106531A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG188117A1 (en) 2008-06-19 2013-03-28 Takeda Pharmaceutical Heterocyclic compound and use thereof
EP2404896A1 (en) 2009-03-05 2012-01-11 Shionogi&Co., Ltd. Cyclohexane derivative having npy y5 receptor antagonism
JP2013503132A (ja) * 2009-08-26 2013-01-31 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング メチルピロロピリジンカルボキサミド
AR077898A1 (es) 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas
CN103201244B (zh) * 2010-08-26 2015-06-17 阿尔比马尔公司 用于制备1-溴代-2-(环丙基甲氧基)-5-氟代-4-甲氧基苯的方法
MX2013014888A (es) 2011-06-17 2014-02-27 Takeda Gmbh Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida.
US10527935B2 (en) * 2016-12-31 2020-01-07 Rohm And Haas Electronic Materials Llc Radiation-sensitive compositions and patterning and metallization processes
JP2020097527A (ja) * 2017-03-31 2020-06-25 武田薬品工業株式会社 複素環化合物
JP7450842B2 (ja) 2017-07-07 2024-03-18 蘇州旺山旺水生物医薬股▲ふん▼有限公司 フェニルピリミドン化合物の塩、結晶多形並びにその医薬組成物及び使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754260B1 (fr) * 1996-10-04 1998-10-30 Adir Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US20050124623A1 (en) * 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
AU2006221957A1 (en) * 2005-03-09 2006-09-14 Nycomed Gmbh Amido-substituted 6-phenylphenanthridines

Also Published As

Publication number Publication date
US20110021479A1 (en) 2011-01-27
CN101959890B (zh) 2013-10-30
EA018331B1 (ru) 2013-07-30
BRPI0907863A2 (pt) 2019-09-24
SG188823A1 (en) 2013-04-30
EP2247594A1 (en) 2010-11-10
JP5615187B2 (ja) 2014-10-29
AU2009218507B2 (en) 2014-02-13
MY152061A (en) 2014-08-15
WO2009106531A1 (en) 2009-09-03
AU2009218507A1 (en) 2009-09-03
IL207639A (en) 2013-09-30
CA2711733A1 (en) 2009-09-03
NZ586486A (en) 2012-06-29
EA201001348A1 (ru) 2011-04-29
UA101018C2 (ru) 2013-02-25
JP2011513272A (ja) 2011-04-28
AR070454A1 (es) 2010-04-07
TW200944527A (en) 2009-11-01
IL207639A0 (en) 2010-12-30
CN101959890A (zh) 2011-01-26
MX2010009276A (es) 2010-09-14
CO6341477A2 (es) 2011-11-21
HK1153200A1 (en) 2012-03-23
US8445501B2 (en) 2013-05-21
KR20100136469A (ko) 2010-12-28

Similar Documents

Publication Publication Date Title
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CR8744A (es) Compuestos terapeuticos
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
CO6341477A2 (es) Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
ECSP11010898A (es) Pirrolidina-2-carboxamidas sustituidas
ECSP109953A (es) Derivados de piridazinona
CY1113924T1 (el) Ενωσεις καρβαζολης και θεραπευτικες χρησεις των ενωσεων
NO20083694L (no) Bruk av rylener som markorer for vaesker
NO20073921L (no) Triazoloftalaziner
EA201001124A1 (ru) Производные хинолина и их применение в качестве фунгицидов
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
UY30476A1 (es) Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones.
EA200702002A1 (ru) Замещённые производные пиразолилоксифенила, применяемые в качестве гербицидов
ECSP10010361A (es) Derivados de piridazinona
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
BR0313330A (pt) Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
UA106880C2 (uk) Нові гербіциди
NO20092902L (no) 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]kinolinforbindelser nyttige som PDE5-inhibitorer
ATE478054T1 (de) Benzimidazolderivate
BRPI0514586A (pt) triazolftalazinas
ECSP12011678A (es) Metilpirrolopirimidincarboxamidas
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4